Pharmaceutical Executive May 26, 2022
While patients continue to benefit from increased product launches, the pandemic is still having an impact on caseload.
The 2022 Global Oncology Trend report, compiled by IQVIA Institute for Human Data Science, details how the cancer treatment space is succeeding and struggling. Companies are launching record numbers of new treatments and more patients are receiving cancer treatment globally. Unfortunately, the effects of the pandemic are still causing problems.
According to the report, a record number of new oncology drugs and treatments were launched in 2021. During that year, 30 novel active substances (NASs) were made available across the globe. The report notes, however, that not all of the new drugs were available in every country.
This number is notable, as...
Today's Sponsors
Today's Sponsor